Show simple item record

dc.contributor.authorShvetsova, O
dc.contributor.authorZhirnov, A
dc.contributor.authorGiannelli, FR
dc.contributor.authorCatalano, MA
dc.contributor.authorCatalano, O
dc.date.accessioned2022-03-21T10:46:41Z
dc.date.issued2021-10-11
dc.date.updated2022-03-20T09:12:59Z
dc.description.abstractINTRODUCTION: This study connects the aggregate strength of public health policies taken in response to the COVID-19 pandemic in the U.S. states to the governors' party affiliations and to state-level outcomes. Understanding the relationship between politics and public health measures can better prepare American communities for what to expect from their governments in a future crisis and encourage advocacy for delegating public health decisions to medical professionals. METHODS: The public health Protective Policy Index captures the strength of policy response to COVID-19 at the state level. The authors estimated a Bayesian model that links the rate of disease spread to Protective Policy Index. The model also accounted for the possible state-specific undercounting of cases and controls for state population density, poverty, number of physicians, cardiovascular disease, asthma, smoking, obesity, age, racial composition, and urbanization. A Bayesian linear model with natural splines of time was employed to link the dynamics of Protective Policy Index to governors' party affiliations. RESULTS: A 10-percentage point decrease in Protective Policy Index was associated with an 8% increase in the expected number of new cases. Between late March and November 2020 and at the state-specific peaks of the pandemic, the Protective Policy Index in the states with Democratic governors was about 10‒percentage points higher than in the states with Republican governors. CONCLUSIONS: Public health measures were stricter in the Democrat-led states, and stricter public health measures were associated with a slower growth of COVID-19 cases. The apparent politicization of public health measures suggests that public health decision making by health professionals rather than by political incumbents could be beneficial.en_GB
dc.format.extent433-437
dc.format.mediumPrint-Electronic
dc.identifier.citationVol. 62(3), pp. 433-437en_GB
dc.identifier.doihttps://doi.org/10.1016/j.amepre.2021.09.003
dc.identifier.urihttp://hdl.handle.net/10871/129103
dc.identifierORCID: 0000-0002-2978-8239 (Zhirnov, Andrei)
dc.language.isoenen_GB
dc.publisherElsevier / American College of Preventive Medicine / Association for Prevention Teaching and Researchen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/34756754en_GB
dc.rights.embargoreasonUnder embargo until 11 October 2022 in compliance with publisher policyen_GB
dc.rights© 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/  en_GB
dc.subjectBayes Theoremen_GB
dc.subjectCOVID-19en_GB
dc.subjectHumansen_GB
dc.subjectPandemicsen_GB
dc.subjectPoliticsen_GB
dc.subjectPublic Policyen_GB
dc.subjectSARS-CoV-2en_GB
dc.subjectUnited Statesen_GB
dc.titleGovernor's Party, Policies, and COVID-19 Outcomes: Further Evidence of an Effecten_GB
dc.typeArticleen_GB
dc.date.available2022-03-21T10:46:41Z
dc.identifier.issn0749-3797
exeter.place-of-publicationNetherlands
dc.descriptionThis is the author accepted manuscript. The final version is available from Elsevier via the DOI in this recorden_GB
dc.identifier.eissn1873-2607
dc.identifier.journalAmerican Journal of Preventive Medicineen_GB
dc.relation.ispartofAm J Prev Med, 62(3)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_GB
dcterms.dateAccepted2021-09-07
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2021-10-11
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-03-21T09:54:14Z
refterms.versionFCDAM
refterms.dateFOA2022-10-10T23:00:00Z
refterms.panelCen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/  
Except where otherwise noted, this item's licence is described as © 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/